The Clinical Trial to Evaluate the Efficacy and Safety of CKD-497

PHASE2CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

May 29, 2018

Primary Completion Date

March 21, 2019

Study Completion Date

March 21, 2019

Conditions
Respiratory Infection
Interventions
DRUG

CKD-497 200mg

CKD-497 200mg

DRUG

CKD-497 300mg

CKD-497 300mg

DRUG

CKD-497 placebo

Placebo of CKD-497

DRUG

Comparator

Comparator

DRUG

Comparator placebo

Comparator placebo

Trial Locations (15)

Unknown

Ulsan University Hospital, Ulsan

KyungHee University Medical Center, Seoul

Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul

Hallym University Chuncheon Sacred Heart Hospital, Chuncheon

Wonju Severance Christian Hospital, Wŏnju

Konkuk University Medical Center, Seoul

Hanyang University Guri Hospital, Guri-si

Hallym University Sacred Heart Hospital, Anyang-si

Kangbuk Samsung Hospital, Seoul

Kangdong Sacred Heart Hospital, Seoul

Gachon University Gil Medical Center, Incheon

The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul

Korea University Anam hospital, Seoul

EWHA Womans University Mokdong Hospital, Seoul

The Catholic University of Korea, Yeouido ST. Mary's Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT03726853 - The Clinical Trial to Evaluate the Efficacy and Safety of CKD-497 | Biotech Hunter | Biotech Hunter